{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-008486","form_type":"8-K","ticker":"LMMY","cik":"0001939937","company_name":"Exousia Bio, Inc.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.113900+00:00","generated_at":"2026-05-16T19:24:25.144564+00:00","sec_items":["1.01","5.01","2.01","3.02","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"LAMY acquires Exousia Ai in reverse merger; appoints Matthew Dwyer as sole officer and director","bullets":["Closed acquisition of Exousia Ai, issuing 62,223,000 shares of common stock to Exousia Ai shareholders.","Zhang Shengwu resigned as sole officer/director; Matthew Dwyer appointed as replacement effective November 17, 2025.","Exousia Ai is a clinical-stage biotech developing plant-based exosome therapies, initially for oncology.","Exousia Ai received FDA Orphan Drug Designation in November 2025 for its exosome-based glioblastoma multiforme (GBM) treatment.","The Company adopts Exousia Ai's business plan and expects to use its proprietary exosome loading technology."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-008486","json":"https://secwatch.observer/filing/0001683168-25-008486.json","markdown":"https://secwatch.observer/filing/0001683168-25-008486.md","text":"https://secwatch.observer/filing/0001683168-25-008486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/lamy_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:24:25.144564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34a9d3864b95fd55150ace47281400cc13cba9f3","claim":"Exousia Bio, Inc. completed an acquisition involving Exousia Ai, Inc. for 62,223,000 shares of Company common stock (closed 2025-11-17).","evidence_excerpt":"of the issued and outstanding capital stock of Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a total of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia Ai. On November 17, 2025, the parties closed the Reorganization Agreement, such that","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001628280-26-032558","ticker":"APAD","company_name":"Enhanced Group Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M","event_type":"m_and_a","sec_items":["1.01","2.01","5.06","3.02","9.01","4.01","3.01","3.03","5.01","5.02","5.03","5.05","7.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-032558","json":"https://secwatch.observer/filing/0001628280-26-032558.json","markdown":"https://secwatch.observer/filing/0001628280-26-032558.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1956439/000162828026032558/0001628280-26-032558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1956439/000162828026032558/apadu-20260506.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"On May 7, 2026, as contemplated by the Business Combination Agreement and as described in the section titled “ The BCA Proposal ” beginning on pa ge 180 of the Proxy Statement/Prospectus, the Company, Enhanced and Merger Sub consummated the business combination contemplated by the Business Combination Agreement, whereby: • Merger Sub merged with and into Enhanced (the “First Merger”), with Enhanced surviving the merger as a wholly owned subsidiary of the Company;","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1956439/000162828026032558/0001628280-26-032558-index.htm"}},{"accession":"0001493152-26-021330","ticker":"CHRN","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.","event_type":"m_and_a","sec_items":["1.01","2.01","2.02","3.02","3.03","4.01","5.01","5.02","5.03","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021330","json":"https://secwatch.observer/filing/0001493152-26-021330.json","markdown":"https://secwatch.observer/filing/0001493152-26-021330.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/form8-ka.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm"}},{"accession":"0001213900-26-044239","ticker":null,"company_name":"Ionetix Corp / DE /","filed_at":"2026-04-16T23:59:59+00:00","headline":"Ionetix Corporation completes reverse merger with JDEV Acquisition Corp., raises $32.3 million","event_type":"m_and_a","sec_items":["2.01","3.02","1.01","3.03","4.01","5.01","9.01","5.02","5.03","5.06"],"materiality_score":1.0,"calibrated_materiality_score":1.0,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-044239","json":"https://secwatch.observer/filing/0001213900-26-044239.json","markdown":"https://secwatch.observer/filing/0001213900-26-044239.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2108121/000121390026044239/0001213900-26-044239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2108121/000121390026044239/ea0286092-8k_ionetix.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"On April 9, 2026, our wholly-owned subsidiary, JDEV Merger Subsidiary, a corporation formed in the State of Delaware on April 9, 2026 (“Merger Sub”), merged with and into Ionetix Corporation, a privately held Delaware corporation (“Ionetix”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2108121/000121390026044239/0001213900-26-044239-index.htm"}},{"accession":"0001104659-26-043237","ticker":"RMIX","company_name":"Suncrete, Inc.","filed_at":"2026-04-14T23:59:59+00:00","headline":"Suncrete closes SPAC merger with Haymaker; begins trading as RMIX on Nasdaq","event_type":"m_and_a","sec_items":["1.01","2.01","5.02","3.02","9.01","4.01","3.03","5.01","5.03","5.05","5.06"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-043237","json":"https://secwatch.observer/filing/0001104659-26-043237.json","markdown":"https://secwatch.observer/filing/0001104659-26-043237.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2094433/000110465926043237/0001104659-26-043237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2094433/000110465926043237/tm2611641d1_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"On April 8, 2026 (the “Closing Date”), Suncrete, Inc. (the “Company”) consummated its previously announced business combination (the “Closing”) pursuant to that certain Business Combination Agreement, dated October 9, 2025 (the “Business Combination Agreement”), by and among the Company, Haymaker Acquisition Corp. 4, a Cayman Islands exempted company (“Haymaker” or “SPAC”), Haymaker Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub I”), Haymaker Merger Sub II, LLC, a Delaware limited liability company and direct wholly owned subsidiary of the Company (“Merger Sub II”), and Concrete Partners Holding, LLC, a Delaware limited liability company (“Suncrete”)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2094433/000110465926043237/0001104659-26-043237-index.htm"}},{"accession":"0001104659-26-043241","ticker":null,"company_name":"Haymaker Acquisition Corp. 4","filed_at":"2026-04-14T23:59:59+00:00","headline":"Haymaker completes business combination with Suncrete; begins trading as RMIX on Nasdaq","event_type":"m_and_a","sec_items":["1.01","2.01","5.02","3.02","9.01","4.01","3.03","5.01","5.03","5.05","5.06"],"materiality_score":1.0,"calibrated_materiality_score":1.0,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-043241","json":"https://secwatch.observer/filing/0001104659-26-043241.json","markdown":"https://secwatch.observer/filing/0001104659-26-043241.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1970509/000110465926043241/0001104659-26-043241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1970509/000110465926043241/tm2611677d2_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"On April 8, 2026 (the “Closing Date”), Suncrete, Inc. (the “Company”) consummated its previously announced business combination (the “Closing”)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1970509/000110465926043241/0001104659-26-043241-index.htm"}},{"accession":"0001193125-26-251758","ticker":"OCFC","company_name":"OCEANFIRST FINANCIAL CORP","filed_at":"2026-06-01T21:19:28+00:00","headline":"OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus","event_type":"m_and_a","sec_items":["1.01","3.02","2.01","2.03","3.03","5.02","5.03","7.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251758","json":"https://secwatch.observer/filing/0001193125-26-251758.json","markdown":"https://secwatch.observer/filing/0001193125-26-251758.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/0001193125-26-251758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/d145829d8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"of Flushing (“ Flushing Common Stock ”) issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, was converted into the right to receive 0.85 of a share (the “ Exchange Ratio ”) of common stock, par value $0.01 per share, of OceanFirst (“ OceanFirst Common Stock ” and such consideration, the “ Merger Consideration ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/0001193125-26-251758-index.htm"}},{"accession":"0001193125-26-213462","ticker":"EWCZ","company_name":"European Wax Center, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"European Wax Center completes take-private by General Atlantic at $5.80/share; stock delisted","event_type":"m_and_a","sec_items":["1.01","1.02","2.01","2.03","3.01","3.03","5.02","5.03","5.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.01, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-213462","json":"https://secwatch.observer/filing/0001193125-26-213462.json","markdown":"https://secwatch.observer/filing/0001193125-26-213462.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856236/000119312526213462/0001193125-26-213462-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856236/000119312526213462/d137291d8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"excluded shares pursuant to the terms of the Merger Agreement, was cancelled and extinguished and automatically converted into the right to receive an amount in cash equal to $5.80 per share of Class A Common Stock, without interest thereon (the “ Class A Per Share Price ”), (ii) each share of the Company’s Class B common stock, par value $0.00001 per share","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1856236/000119312526213462/0001193125-26-213462-index.htm"}},{"accession":"0001493152-26-021767","ticker":"SHPH","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Shuttle Pharma completes merger with United Dogecoin, pivots to crypto, raises $9.55M PIPE","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","3.03","5.02","5.03","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 5.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021767","json":"https://secwatch.observer/filing/0001493152-26-021767.json","markdown":"https://secwatch.observer/filing/0001493152-26-021767.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757499/000149315226021767/0001493152-26-021767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757499/000149315226021767/form8-k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm","comparable_excerpt":"On May 6, 2026 (the “ Closing Date ”), Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), completed its previously announced merger pursuant to an Agreement and Plan of Merger (the “ Merger Agreement ”), entered into on April 30, 2026 by and among the Acquiror, Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1757499/000149315226021767/0001493152-26-021767-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}